← Back to Clinical Trials
Recruiting Phase 3 NCT06003101

Effect of PRP, PPP, & BMAC on Functional Outcomes Following Hip Arthroscopy for Acetabular Labral Pathologies

Trial Parameters

Condition Acetabular Labrum Tear
Sponsor Massachusetts General Hospital
Study Type INTERVENTIONAL
Phase Phase 3
Enrollment 160
Sex ALL
Min Age 18 Years
Max Age N/A
Start Date 2023-08-30
Completion 2027-08-30
Interventions
Bone marrow aspirate concentrate (BMAC)Control

Brief Summary

The goal of this clinical trial is to assess the effect of PRP/PPP/BMAC application on functional outcomes after hip arthroscopy to address acetabular labral pathologies. The main questions it aims to answer are: 1. Does PRP/PPP/BMAC application improve functional outcomes after hip arthroscopy to address acetabular labral pathologies? 2. Does PRP/PPP/BMAC application reduce the arthritic burden as measured by functional outcomes following hip arthroscopy to address labral pathologies with concomitant PRP/PPP/BMAC application?

Eligibility Criteria

Inclusion Criteria: * Age: \> or equal to 18 years * Clinically indicated for hip arthroscopy (by the study PI) to address a labral pathology * Willingness to participate, amenable to randomization into either treatment arm of the research study, and the ability to understand \& sign the informed consent document Exclusion Criteria: * Non-English speaking (PROM surveys are only validated in English) * Prior same site (i.e., ipsilateral hip) surgery, including but not limited to previous hip arthroscopy, core decompression, or periacetabular osteotomies

Related Trials